Publication | Open Access
Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe
62
Citations
17
References
2020
Year
It takes a long time for patients to get access to newly registered cancer drugs and there is great variation in access. The health outcomes can be substantially improved by faster processes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1